8-K - United Therapeutics Corporation | StockGist

Current Report Details

Event Type

Management Change+3 More

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January

Management Change

$120.0K

5.03

. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On January 21, 2026, the Board also approved amendments to, and the restatement of,

Charter Amendment

7.01

and Exhibit 99.1 attached hereto are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amend

Regulation Fd

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description of Exhibit 3.1 Eleventh Amended and Restated Bylaws of United Therapeutics Corporation

Exhibits Only

Source Document

Exhibits (3)

3.1

EXHIBIT 3.1

8-K

FORM 8-K

99.1

EXHIBIT 99.1